Singer Capital Markets Securities Ltd, an exempt principal trader, disclosed dealings in HIPGNOSIS SONGS FUND LTD's securities on 19th July 2024. The transactions included purchases and sales of ORD NVP securities, with 15,492 securities purchased and 11,922 securities sold. The highest price per unit paid for the purchases was 100.804p, while the lowest price per unit paid was 100.6p. The highest price per unit received for the sales was 100.8p, and the lowest price per unit received was 100.6p.

The disclosure also confirmed that there were no cash-settled derivative transactions, stock-settled derivative transactions, or other dealings, including subscribing for new securities. Additionally, there were no indemnity or other dealing arrangements, agreements, arrangements, or understandings relating to options or derivatives.

The disclosure was made in accordance with Rule 8 of the Takeover Code and was addressed to a Regulatory Information Service. The contact person for the disclosure was Jennifer Bentick, and the date of disclosure was 22nd July 2024.

For any consultation regarding the Code's dealing disclosure requirements, the Panel's Market Surveillance Unit can be reached at +44 (0)20 7638 0129.

This summary provides an overview of Singer Capital Markets Securities Ltd's recent dealings in HIPGNOSIS SONGS FUND LTD's securities, as per the disclosure made under Rule 8 of the Takeover Code.